ONCIN Oncoinvent ASA

7.550USD73.00 NOK · OSL+2.53%Mkt Cap: 46.27M USDP/E: —

Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body…